{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T10:40:06Z","timestamp":1751193606238,"version":"3.41.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,29]]},"DOI":"10.7759\/cureus.86948","type":"journal-article","created":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T09:58:28Z","timestamp":1751191108000},"source":"Crossref","is-referenced-by-count":0,"title":["Assessment of Knowledge and General Attitudes of Primary Care Physicians Toward Dipeptidyl Peptidase-4 (DPP-4) Inhibitor Drugs in the Management of Type 2 Diabetes Mellitus in the Qassim Region"],"prefix":"10.7759","author":[{"given":"Faisal","family":"Aljulajil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Unaib","family":"Rabbani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"IDF Diabetes Atlas. (2024). Accessed. 17 June 2025: https:\/\/diabetesatlas.org."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"402","author":"GBD 2021 Diabetes Collaborators","year":"2023","unstructured":"GBD 2021 Diabetes Collaborators. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023, 402:203-34. 10.1016\/S0140-6736(23)01301-6","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)61032-X","article-title":"Type 2 diabetes: principles of pathogenesis and therapy","volume":"365","author":"Stumvoll M","year":"2005","unstructured":"Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet. 2005, 365:1333-46. 10.1016\/S0140-6736(05)61032-X","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/s0889-8529(05)70322-4","article-title":"Epidemiology of late diabetic complications: a basis for the development and evaluation of preventive programs","volume":"25","author":"Krolewski AS","year":"1996","unstructured":"Krolewski AS, Warram JH, Freire MB. Epidemiology of late diabetic complications: a basis for the development and evaluation of preventive programs. Endocrinol Metab Clin North Am. 1996, 25:217-42. 10.1016\/s0889-8529(05)70322-4","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24234209","article-title":"Nanoparticle delivery systems in the treatment of diabetes complications","volume":"24","author":"Souto EB","year":"2019","unstructured":"Souto EB, Souto SB, Campos JR, et al.. Nanoparticle delivery systems in the treatment of diabetes complications. Molecules. 2019, 24:4209. 10.3390\/molecules24234209","journal-title":"Molecules"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2017.09.003","article-title":"Potential of insulin nanoparticle formulations for oral delivery and diabetes treatment","volume":"264","author":"Wong CY","year":"2017","unstructured":"Wong CY, Al-Salami H, Dass CR. Potential of insulin nanoparticle formulations for oral delivery and diabetes treatment. J Control Release. 2017, 264:247-75. 10.1016\/j.jconrel.2017.09.003","journal-title":"J Control Release"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2004.07.033","article-title":"A comparison of the dynamic behavior of monomeric and dimeric insulin shows structural rearrangements in the active monomer","volume":"342","author":"Zoete V","year":"2004","unstructured":"Zoete V, Meuwly M, Karplus M. A comparison of the dynamic behavior of monomeric and dimeric insulin shows structural rearrangements in the active monomer. J Mol Biol. 2004, 342:913-29. 10.1016\/j.jmb.2004.07.033","journal-title":"J Mol Biol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2174\/1871529x14666140701095849","article-title":"Alogliptin; a review of a new dipeptidyl peptidase-4 (DPP-4) inhibitor for the treatment of type 2 diabetes mellitus","volume":"14","author":"Said S","year":"2014","unstructured":"Said S, Nwosu AC, Mukherjee D, Hernandez GT. Alogliptin; a review of a new dipeptidyl peptidase-4 (DPP-4) inhibitor for the treatment of type 2 diabetes mellitus. Cardiovasc Hematol Disord Drug Targets. 2014, 14:64-70. 10.2174\/1871529x14666140701095849","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5308582","article-title":"DPP-4 inhibitors as treatments for type 1 diabetes mellitus: a systematic review and meta-analysis","volume":"2018","author":"Wang Q","year":"2018","unstructured":"Wang Q, Long M, Qu H, et al.. DPP-4 inhibitors as treatments for type 1 diabetes mellitus: a systematic review and meta-analysis. J Diabetes Res. 2018, 2018:5308582. 10.1155\/2018\/5308582","journal-title":"J Diabetes Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.12063","article-title":"Dipeptidyl peptidase-4 inhibitors: multitarget drugs, not only antidiabetes drugs","volume":"6","author":"Zhao Y","year":"2014","unstructured":"Zhao Y, Yang L, Zhou Z. Dipeptidyl peptidase-4 inhibitors: multitarget drugs, not only antidiabetes drugs. J Diabetes. 2014, 6:21-9. 10.1111\/1753-0407.12063","journal-title":"J Diabetes"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4103\/0253-7613.70405","article-title":"Sitagliptin-induced hemolysis","volume":"42","author":"Bekur R","year":"2010","unstructured":"Bekur R, Nagaraja MV, Shivashankara KN, Stanley W. Sitagliptin-induced hemolysis. Indian J Pharmacol. 2010, 42:320-1. 10.4103\/0253-7613.70405","journal-title":"Indian J Pharmacol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2010.10.004","article-title":"Severe leucopenia associated with sitagliptin use","volume":"91","author":"Pitocco D","year":"2011","unstructured":"Pitocco D, Zaccardi F, Martini F, Scavone G, Musella T, Caputo S, Ghirlanda G. Severe leucopenia associated with sitagliptin use. Diabetes Res Clin Pract. 2011, 91:e30-2. 10.1016\/j.diabres.2010.10.004","journal-title":"Diabetes Res Clin Pract"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.109.135244","article-title":"Angiotensin-converting enzyme and dipeptidyl peptidase IV inhibitors: an increased risk of angioedema","volume":"54","author":"Grouzmann E","year":"2009","unstructured":"Grouzmann E, Livio F, Buclin T. Angiotensin-converting enzyme and dipeptidyl peptidase IV inhibitors: an increased risk of angioedema. Hypertension. 2009, 54:468-70. 10.1161\/HYPERTENSIONAHA.109.135244","journal-title":"Hypertension"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2019.07.034","article-title":"Primary care physicians' knowledge, attitudes and practices related to\u00a0metabolic syndrome screening and management in Alahsa, Saudi Arabia","volume":"13","author":"Alali AA","year":"2019","unstructured":"Alali AA, Albagshi NM, Albin Alshaikh SM, Almubarak AA. Primary care physicians' knowledge, attitudes and practices related to\u00a0metabolic syndrome screening and management in Alahsa, Saudi Arabia. Diabetes Metab Syndr. 2019, 13:2689-97. 10.1016\/j.dsx.2019.07.034","journal-title":"Diabetes Metab Syndr"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/7328128","article-title":"Diabetes-related distress assessment among type 2 diabetes patients","volume":"2018","author":"Aljuaid MO","year":"2018","unstructured":"Aljuaid MO, Almutairi AM, Assiri MA, Almalki DM, Alswat K. Diabetes-related distress assessment among type 2 diabetes patients. J Diabetes Res. 2018, 2018:7328128. 10.1155\/2018\/7328128","journal-title":"J Diabetes Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.038352","article-title":"Linagliptin effects on heart failure and related outcomes in individuals with type 2 diabetes mellitus at high cardiovascular and renal risk in Carmelina","volume":"139","author":"McGuire DK","year":"2019","unstructured":"McGuire DK, Alexander JH, Johansen OE, et al.. Linagliptin effects on heart failure and related outcomes in individuals with type 2 diabetes mellitus at high cardiovascular and renal risk in Carmelina. Circulation. 2019, 139:351-61. 10.1161\/CIRCULATIONAHA.118.038352","journal-title":"Circulation"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2021.12.019","article-title":"Prescribing patterns of antidiabetics in type 2 diabetes and factors affecting them","volume":"30","author":"Allyhiani M","year":"2022","unstructured":"Allyhiani M, Kurdi A, Abdulaziz A, et al.. Prescribing patterns of antidiabetics in type 2 diabetes and factors affecting them. Saudi Pharm J. 2022, 30:112-9. 10.1016\/j.jsps.2021.12.019","journal-title":"Saudi Pharm J"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0306296","article-title":"Effectiveness of shared decision-making for glycaemic control among type 2 diabetes mellitus adult patients: a systematic review and meta-analysis","volume":"19","author":"Geta ET","year":"2024","unstructured":"Geta ET, Terefa DR, Hailu WB, et al.. Effectiveness of shared decision-making for glycaemic control among type 2 diabetes mellitus adult patients: a systematic review and meta-analysis. PLoS One. 2024, 19:e0306296. 10.1371\/journal.pone.0306296","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1307684","article-title":"Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus","volume":"369","author":"Scirica BM","year":"2013","unstructured":"Scirica BM, Bhatt DL, Braunwald E, et al.. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. N Engl J Med. 2013, 369:1317-26. 10.1056\/NEJMoa1307684","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000040865","article-title":"Primary health care professionals' opinions regarding continuing medical education: a cross sectional study","volume":"103","author":"Hassan Alshehri HM","year":"2024","unstructured":"Hassan Alshehri HM, Alshehri AM, Alshehri AM, et al.. Primary health care professionals' opinions regarding continuing medical education: a cross sectional study. Medicine (Baltimore). 2024, 103:e40865. 10.1097\/MD.0000000000040865","journal-title":"Medicine (Baltimore)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2019.0070","article-title":"Current status and future directions for electronic point-of-care clinical decision support to improve diabetes management in primary care","volume":"21","author":"O'Connor PJ","year":"2019","unstructured":"O'Connor PJ, Sperl-Hillen JM. Current status and future directions for electronic point-of-care clinical decision support to improve diabetes management in primary care. Diabetes Technol Ther. 2019, 21:S226-34. 10.1089\/dia.2019.0070","journal-title":"Diabetes Technol Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/375298-assessment-of-knowledge-and-general-attitudes-of-primary-care-physicians-toward-dipeptidyl-peptidase-4-dpp-4-inhibitor-drugs-in-the-management-of-type-2-diabetes-mellitus-in-the-qassim-region","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T09:58:29Z","timestamp":1751191109000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/375298-assessment-of-knowledge-and-general-attitudes-of-primary-care-physicians-toward-dipeptidyl-peptidase-4-dpp-4-inhibitor-drugs-in-the-management-of-type-2-diabetes-mellitus-in-the-qassim-region"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,29]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.86948","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,6,29]]}}}